ライフサイエンスコーパス: nephrogenic systemic fibrosis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 None of the neonates developed nephrogenic systemic fibrosis.

2 ystemic fibrosis and ectopic ossification in nephrogenic systemic fibrosis.

3 ts with severe renal dysfunction at risk for nephrogenic systemic fibrosis.

4 Nephrogenic systemic fibrosis, also known as nephrogenic

5 e recent association of this lanthanide with nephrogenic systemic fibrosis, an untreatable disease, h

6 imuli may participate in the pathogenesis of nephrogenic systemic fibrosis and of other fibrotic diso

7 Clinical reports support the evidence of nephrogenic systemic fibrosis as a systemic disease and

8 Gd(3+) and potential side effects including nephrogenic systemic fibrosis have led to the search for

9 dolinium-based contrast agents are linked to nephrogenic systemic fibrosis in patients with renal ins

10 lain their causal role in the development of nephrogenic systemic fibrosis in renally impaired patien

11 Nephrogenic systemic fibrosis is a new disorder reported

12 The pathology of nephrogenic systemic fibrosis is characterized by abnorm

13 Clinical awareness of nephrogenic systemic fibrosis is still emerging and futu

14 g that gadoxetate disodium does not incite a nephrogenic systemic fibrosis-like fibrotic change in th

15 bodies were thought to be pathognomonic for nephrogenic systemic fibrosis (NSF) in the setting of ch

16 Nephrogenic systemic fibrosis (NSF) is a fibrosing skin

17 Nephrogenic systemic fibrosis (NSF) is a rapidly progres

18 Nephrogenic systemic fibrosis (NSF) is a severe fibrosin

19 Nephrogenic systemic fibrosis (NSF) is associated with g

20 m patients with systemic sclerosis (SSc) and nephrogenic systemic fibrosis (NSF) was performed to ide

21 sented as a novel means for the diagnosis of nephrogenic systemic fibrosis (NSF), a rare disease occu

22 disease, have been strongly associated with nephrogenic systemic fibrosis (NSF), a severe systemic f

23 ew data in 13 patients with biopsy-confirmed nephrogenic systemic fibrosis (NSF), assess the associat

24 e a small risk of adverse effects, including nephrogenic systemic fibrosis (NSF), the untreatable con

25 eir product labeling to describe the risk of nephrogenic systemic fibrosis (NSF).

26 connective tissue or skin disease resembling nephrogenic systemic fibrosis (NSF-like) and a broader s

27 o uniformly effective interventions to treat nephrogenic systemic fibrosis other than successful rena

28 lls in the fibrotic and calcified tissues of nephrogenic systemic fibrosis patients.

29 While a specific cause of nephrogenic systemic fibrosis remains to be established,

30 pe and function relevant to the pathology of nephrogenic systemic fibrosis using immunofluorescence,

31 We also examined tissues from patients with nephrogenic systemic fibrosis, using IHC to identify the

32 ased contrast agents in patients at risk for nephrogenic systemic fibrosis was recently shown to avoi

33 cts) and from lesional skin of patients with nephrogenic systemic fibrosis were exposed to a range of

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。